Showing 19,021 - 19,040 results of 27,402 for search '(( 50 ((we decrease) OR (((mean decrease) OR (a decrease)))) ) OR ( 2 teer decrease ))', query time: 0.62s Refine Results
  1. 19021

    Residual polysaccharides from fungi reduce the bacterial spot in tomato plants by Tarsis Aguiar (5021966)

    Published 2018
    “…Furthermore, PRC and PSHII (1.5 mg.mL–1) could decrease disease severity in all tested cultivars. …”
  2. 19022

    The in vitro pancreatic cancer cell line model. by Diána Brauswetter (723331)

    Published 2017
    “…Panc1 shows resistance to MEK inhibitors and the combination with the EGFR inhibitor afatinib does not decrease its IC<sub>50</sub> concentration to an appropriate level. …”
  3. 19023

    MO neurons are not required for synchronization to temperature cycles in constant light. by Clara Lorber (14106749)

    Published 2022
    “…<p>A) Double plotted average actograms of the indicated genotypes. …”
  4. 19024

    MSCs on endothelial ECM appeared more spindle-like morphology. by Ming-Kang Lee (4401568)

    Published 2017
    “…<p>(A) MSCs at passage 2 (upper panel, scale bar: 200 μm) and passage 4 (lower panel, scale bar: 50 μm) of each group showed various morphologies. …”
  5. 19025

    Effects of mCAR ligands alone or in combination with Paclitaxel in E9 mouse lung cancer cells. by Heidge Fukumasu (588307)

    Published 2014
    “…(B) Effects of mCAR ligands on the anti-tumor efficacy of paclitaxel (IC50). TCPOBOP increases the anti-tumor efficacy of the of paclitaxel by significant decrease cell viability at 1–10 µM compared to only paclitaxel-treated cells (p<0.05 – Two way ANOVA followed by Tukey's multiple comparison test for treatment effect). …”
  6. 19026

    Effects of mCAR ligands alone or in combination with Paclitaxel in E9 mouse lung cancer cells. by Heidge Fukumasu (588307)

    Published 2014
    “…(B) Effects of mCAR ligands on the anti-tumor efficacy of paclitaxel (IC50). TCPOBOP increases the anti-tumor efficacy of the of paclitaxel by significant decrease cell viability at 1–10 µM compared to only paclitaxel-treated cells (p<0.05 – Two way ANOVA followed by Tukey's multiple comparison test for treatment effect). …”
  7. 19027
  8. 19028
  9. 19029
  10. 19030
  11. 19031
  12. 19032
  13. 19033
  14. 19034
  15. 19035
  16. 19036
  17. 19037
  18. 19038
  19. 19039
  20. 19040